Medipharm Labs Corp.

OTC: MEDIF

GO
/marketstate/country/us

Market open

 --Quotes are delayed by 20 min

May 17, 2021, 1:52 p.m.

/zigman2/quotes/203412746/composite

$

0.33

Change

-0.0019 -0.57%

Volume

Volume 250,698

Quotes are delayed by 20 min

/zigman2/quotes/203412746/composite

Previous close

$ 0.34

$ 0.33

Change

-0.0019 -0.57%

Day low

Day high

$0.33

$0.34

Open

52 week low

52 week high

$0.32

$1.53

Open

Annual Financials for Medipharm Labs Corp.

Fiscal year is January-December. All values CAD millions. 201820192020 5-year trend
Sales/Revenue --10.2M129.25M36.01M
Cost of Goods Sold (COGS) incl. D&A --7.08M87.55M81.87M
COGS excluding D&A --6.1M85.02M71.06M
Depreciation & Amortization Expense --982,0002.53M10.81M
Depreciation --982,0002.53M10.8M
Amortization of Intangibles ----4,000
Gross Income --3.12M41.7M(45.86M)
201820192020 5-year trend
SG&A Expense --6.87M33.85M29.84M
Research & Development --261,000621,0002.23M
Other SG&A --6.61M33.23M27.62M
Other Operating Expense ----(7,000)
Unusual Expense --4.23M480,000(6.04M)
EBIT after Unusual Expense --(7.98M)7.38M(69.66M)
Non Operating Income/Expense --(63,000)(413,000)5.18M
Non-Operating Interest Income --64,000486,000273,000
Equity in Affiliates (Pretax) -----
Interest Expense --485,000699,0007.89M
Gross Interest Expense --485,000699,0007.89M
Interest Capitalized -----
Pretax Income --(8.47M)6.75M(72.1M)
Income Tax ---5.62M(4.99M)
Income Tax - Current Domestic ---5.04M(4.41M)
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic ---578,000(578,000)
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income --(8.47M)1.13M(67.11M)
Minority Interest Expense --(80,000)(514,000)(757,000)
Net Income --(8.39M)1.65M(66.35M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(8.39M)1.65M(66.35M)
Preferred Dividends -----
Net Income Available to Common --(8.39M)1.65M(66.35M)
EPS (Basic) --(0.12)0.01(0.48)
Basic Shares Outstanding --72.59M120M138.55M
EPS (Diluted) --(0.12)0.01(0.48)
Diluted Shares Outstanding --72.59M134.63M138.55M
EBITDA --(2.77M)10.39M(64.89M)
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.